Recursion (RXRX) acquires full rights to oral HPP treatment REV102

Go back to Recursion (RXRX) acquires full rights to oral HPP treatment REV102
(NASDAQ: RLYB) Delayed: 16.38 --0 (-0%)
Previous Close $16.38    52 Week High
Open $16.38    52 Week Low
Day High $16.38    P/E N/A 
Day Low $16.38    EPS
Volume 113       

(NASDAQ: RXRX) Delayed: 3.35 --0 (-0%)
Previous Close $3.35    52 Week High
Open $3.35    52 Week Low
Day High $3.35    P/E N/A 
Day Low $3.35    EPS
Volume 31,513